NCT04779424

Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19)

Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium During One Year of the COVID-19 Epidemic

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 3,390 (actual)
• Sponsor: Universiteit Antwerpen · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This protocol focuses on the seroprevalence in primary care health care providers (PHCPs) in Belgium. PHCPs manage the vast majority of COVID-19 and other patients and therefore are essential to organize health care efficiently. Currently however, evidence is lacking on 1. how many PHCPs get infected or diseased in Belgium, 2. the rate at which this happens, 3. their clinical spectrum, 4. their risk factors, 5. the effectiveness of the measures to prevent this from happening and 6. the accuracy of the immunological serology-based point-of-care test in a primary care setting. This study will be set up as a prospective cohort study. All Belgian GPs in clinical practice will be invited to register online for participation in this national epidemiological study and will be asked to invite the other PHCPs in their practice to do the same. A model and demography-informed sample of registered GPs and other PHCPs will be selected. These participants will be asked at each testing point to perform a capillary blood sample antibody point of care test (OrientGene®) and complete an online questionnaire. All data analysis will be performed and reported after each relevant testing period and at the end of the study.

Conditions

• SARS-CoV-2
• COVID-19

Interventions

Type	Name	Description
OTHER	POCT	Capillary blood sample antibody point of care test

Timeline

• Start date: 2020-11-15
• Primary completion: 2021-12-31
• Completion: 2023-03-31
• First posted: 2021-03-03
• Last updated: 2023-12-04

Locations

1 site across 1 country: Belgium